Papanastasiou, A.D.; Peroukidis, S.; Sirinian, C.; Arkoumani, E.; Chaniotis, D.; Zizi-Sermpetzoglou, A.
CD44 Expression in Clear Cell Renal Cell Carcinoma (ccRCC) Correlates with Tumor Grade and Patient Survival and Is Affected by Gene Methylation. Genes 2024, 15, 537.
https://doi.org/10.3390/genes15050537
AMA Style
Papanastasiou AD, Peroukidis S, Sirinian C, Arkoumani E, Chaniotis D, Zizi-Sermpetzoglou A.
CD44 Expression in Clear Cell Renal Cell Carcinoma (ccRCC) Correlates with Tumor Grade and Patient Survival and Is Affected by Gene Methylation. Genes. 2024; 15(5):537.
https://doi.org/10.3390/genes15050537
Chicago/Turabian Style
Papanastasiou, Anastasios D., Stavros Peroukidis, Chaido Sirinian, Elisavet Arkoumani, Dimitrios Chaniotis, and Adamantia Zizi-Sermpetzoglou.
2024. "CD44 Expression in Clear Cell Renal Cell Carcinoma (ccRCC) Correlates with Tumor Grade and Patient Survival and Is Affected by Gene Methylation" Genes 15, no. 5: 537.
https://doi.org/10.3390/genes15050537
APA Style
Papanastasiou, A. D., Peroukidis, S., Sirinian, C., Arkoumani, E., Chaniotis, D., & Zizi-Sermpetzoglou, A.
(2024). CD44 Expression in Clear Cell Renal Cell Carcinoma (ccRCC) Correlates with Tumor Grade and Patient Survival and Is Affected by Gene Methylation. Genes, 15(5), 537.
https://doi.org/10.3390/genes15050537
